Clinical Trial Update: A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase II maintenance trial evaluating cediranib with olaparib for advanced recurrent cervical cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Cediranib (Cediranib)
• Olaparib (Olaparib)

Snippet

Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust | Conditions: Cervical Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING